PD-RX Pharmaceuticals

PD-RX Pharmaceuticals P/FCF

P/FCF (Price-to-Free-Cash-Flow Ratio) of PD-RX Pharmaceuticals (PDRX) as of Oct 10, 2026.

P/FCF

-

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of PD-RX Pharmaceuticals is 2026 - . P/FCF (Price-to-Free-Cash-Flow Ratio) of PD-RX Pharmaceuticals was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

PD-RX Pharmaceuticals Stock analysis

What does PD-RX Pharmaceuticals do? PD-RX Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PD-RX Pharmaceuticals stock

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) PD-RX Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s PD-RX Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — PD-RX Pharmaceuticals

All Key Metrics — PD-RX Pharmaceuticals